Harry Paul Erba

University Of Alabama At Birmingham

$1,273,979

Attributed

$4,333,378

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $682.4K · FY2016–25

$1M$750K$500K$250K$0

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$4,333,378 · 3

By mechanism

UG1$2,623,055 · 1

U10$995,600 · 1

P30$714,723 · 1

Top collaborators

Most similar at University Of Alabama At Birmingham

Same institution · by research overlap

Charles A. Leath$2,454,862
Amitkumar N Mehta$1,687,160
Robert B. Diasio$27,640,960
Robert Floyd Pass$10,874,670
Suzanne Oparil$34,839,156

Others in their field

Top investigators on “Malignant Neoplasms”

David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
Richard K. Wilson · Washington University$274,272,747
Larry Arthur$223,443,122
Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879

Research focus

Malignant NeoplasmsMemberClinical TrialsClinical ResearchFundingInvestigationGrantEvaluationOncologyDiagnosisCancer PreventionEnsureSurvivorshipComprehensive Cancer CenterCancer ControlBasic ScienceMissionAuthorityDisciplineGuidelinesLettersBiometryIntervention TrialCancer Center